alpha-cyano-beta-hydroxy-beta-methyl-N-(2,5-dibromophenyl)propenamide,
LFM A13,
LFM-A13,
lfm-a13,
244240-24-2,
(Z)-2-cyano-N-(2,5-dibromophenyl)-3-hydroxybut-2-enamide,
SMR001230714,
SR-01000075965,
62004-35-7,
C11H8Br2N2O2,
2-Cyano-N-(2,5-dibromophenyl)-3-hydroxy-2-butenamide,
BiomolKI_000050,
BiomolKI2_000056,
LFMA13,
AC1L1H0E,
AC1NS4I5,
Lopac0_000650,
SCHEMBL51142,
BMK1-F2,
BSPBio_001239,
MLS002153290,
MLS006010694,
GTPL9262,
CHEBI:95065,
2-cyano-N-(2,5-dibromophenyl),
HMS1362M21,
HMS1792M21,
HMS1990M21,
HMS2235P16,
HMS3403M21,
HMS3678K07,
BCP12817,
3781AH,
BS0111,
s7734,
ZINC37868487,
AKOS024456516,
CCG-100654,
CS-3890,
LP00650,
IDI1_002205,
NCGC00025100-02,
NCGC00025100-03,
NCGC00025100-04,
NCGC00025100-05,
NCGC00025100-06,
NCGC00025100-07,
NCGC00025100-08,
HY-18009,
LFM-A13, >=98% (HPLC), powder,
LS-45444,
QC-11797,
B5952,
EU-0100650,
K00067,
L 8789,
2-cyano-N-(2,5-dibromophenyl)-3-oxobutanamide,
SR-01000075965-1,
SR-01000075965-3,
(2Z)-2-cyano-N-(2,5-dibromophenyl)-3-hydroxybut-2-enamide,
2-[(2,5-dibromoanilino)-hydroxymethylidene]-3-oxobutanenitrile,
a-Cyano-b-hydroxy-b-methyl-N-(2,5-dibromophenyl)propenamide,
(2Z)-2-CYANO-N-(2,5-DIBROMOPHENYL)-3-HYDROXY-2-BUTENAMIDE,
(2E)-2-[(2,5-dibromoanilino)-hydroxymethylidene]-3-oxobutanenitrile,
(Z)-2-cyano-N-(2,5-dibromophenyl)-3-hydroxybut-2-enamide(LFM-A13),
alpha-cyano-beta-hydroxy-beta-methyl-N-(2, 5-dibromophenyl)propenamide,
(2Z)-2-Cyano-N-(2,5-dibromophenyl)-3-hydroxy-2-butenamide; a-Cyano-b-hydroxy-b-methyl-N-(2,5-dibromophenyl)propenamide,
-3-oxobutanamide,
Lfm A13,
D08NTB,
CHEMBL228043,
LFM-A 13,
CID3921,
CID5353721,
CID9549280,
A16261,
C118451,
alpha-Cyano-beta-hydroxy-beta-methyl-N-(2,5-dibromophenyl)propenamide,
|A-Cyano-|A-hydroxy-|A-methyl-N-(2,5-dibromophenyl)propenamide,